UTI Healthcare Fund - IDCW - Direct Plan

Other Plans and Options
  • (-0.32%)Nav, as on 15-09-2025

  • Previous Nav

  • Net Change on 15-09-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
UTI Healthcare Fund - Direct Plan - IDCW 1.89 4.31 3.31 26.89 20.51 16.58
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Healthcare Fund - Direct Plan - IDCW Jan 01, 2013 3.31 26.89 20.51 1.30 1,118.51
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 -0.74 23.97 20.15 0.89 8,357.03
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 4.30 29.47 22.88 1.04 6,161.81
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 4.69 27.49 22.11 0.91 3,963.38
Mirae Asset Healthcare Fund Direct IDCW Jul 02, 2018 1.43 23.64 20.90 0.49 2,795.84
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 0.02 25.34 21.21 0.62 1,308.56

Fund Holdings as on 31-August-2025

  • EQ - SUN PHARMACEUTICALS INDUSTRIES

  • EQ - CIPLA LTD.

  • EQ - AJANTA PHARMA LTD.

  • EQ - LUPIN LTD.

  • EQ - DR REDDYS LABORATORIES LTD.

  • EQ - PROCTOR & GAMBLE HEALTH LTD

  • EQ - FORTIS HEALTHCARE LTD.

  • EQ - GLENMARK PHARMACEUTICALS LTD.

  • EQ - APOLLO HOSPITALS ENTERPRISE LT

  • EQ - ALKEM LABORATORIES LTD

  • EQ - GLAND PHARMA LTD.

  • EQ - ERIS LIFESCIENCES LTD

  • EQ- JUPITER LIFE LINE HOSPITALS LTD

  • EQ - CAPLIN POINT LABORATORIES LTD

  • EQ - DIVIS LABORATORIES LTD.

  • EQ - COHANCE LIFESCIENCES LIMITED

  • EQ - MAX HEALTHCARE INSTITUTE LTD

  • EQ - AUROBINDO PHARMA LTD.

  • EQ - KRISHNA INSTITUTE OF MEDI SCIE

  • EQ - IPCA LABORATORIES LTD.

  • EQ - METROPOLIS HEALTHCARE LTD

  • EQ- GLOBAL HEALTH LTD.

  • EQ - PFIZER LIMITED

  • EQ - SAI LIFE SCIENCES LTD

  • EQ - ASTER DM HEALTHCARE LTD

  • EQ - ANTHEM BIOSCIENCES LTD

  • EQ - WINDLAS BIOTEC LTD

  • EQ - SEQUENT SCIENTIFIC LTD

  • EQ - BIOCON LTD.

  • EQ - MARKSANS PHARMA LTD.

  • EQ - ACUTAAS CHEMICALS LIMITED

  • EQ - SANOFI CONSUMER HEALTHCARE INDIA LTD

  • EQ - VIJAYA DIAGNOSTIC CENTRE LTD

  • EQ - RAINBOW CHILDRENS MEDICARE LTD

  • EQ - SYNGENE INTERNATIONAL LTD.

  • EQ - TORRENT PHARMACEUTICALS LTD.

  • EQ - EMCURE PHARMACEUTICALS LTD

  • EQ - ALEMBIC PHARMACEUTICALS

  • EQ - JUBILANT PHARMOVA LIMITED

  • EQ - ORCHID PHARMA LTD.

  • NET CURRENT ASSETS

  • EQ - LAXMI DENTAL LIMITED

  • CLEARING CORPORATION OF INDIA LTD. STD - MARGIN

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Deposits

  • Equity

View More

About UTI Healthcare Fund

Scheme Analysis

UTI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to UTI Mutual Fund. It was launched on 01-Jan-2013 and currently has an AUM of ₹1,118.51 crore. UTI Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of UTI Healthcare Fund ended down ₹-0.83(-0.32%)yesterday to ₹257.8292.

Among its top 3 holdings the fund has exposure to EQ - SUN PHARMACEUTICALS INDUSTRIES, and

The UTI Healthcare Fund is managed by Kamal Gada .

Fund House Contact

UTI Towers, Gn Block, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 66786666
service@uti.co.in
+91 (22) 66786503,56786578
www.utimf.com